Mariela Fernanda RAZUC, Fernanda Anabel CABRERA, Mariano Enrique GARRIDO, María Verónica RAMIREZ RIGO

A new reliable and rapid HPLC method for the simultaneous determination of amoxicillin and sulbactam pivoxil in pharmaceuticals. Application to both assay and dissolution samples

A fast, efficient and simple high performance liquid chromatographic method was developed and validated for the simultaneous determination of amoxicillin trihydrate (AMO) and sulbactam pivoxil (SP) in oral pharmaceutical dosage forms and, eventually, for their dissolution tests. The difference in molar absorptivities of these compounds constituted an analytical challenge, especially in formulations where AMO was in a higher proportion than SP. A reverse phase C18 column was used with a mobile phase consisting of acetonitrile and water (80:20 v/v) in isocratic mode. The retention times were found to be 2.26 min and 1.34 min for SP and AMO, respectively. The linearity range was evaluated over the concentration range of 2.5 and 250.0 μg mL-1 (correlation coefficients higher than 0.9998). The method was validated according to the International Conference on Harmonization ICH guidelines regarding selectivity, linearity, accuracy, precision, limit of detection, limit of quantification, system suitability and robustness. The validated method was applied for the quantification of AMO and SP in commercial tablets and oral suspensions (AMO/SP ratio between 1:1 and 7:1), being the first method in the open literature that enables the correct quantification of both active ingredients in formulations with an AMO/SP ratio higher than 1:1. Also, the new method was successfully applied for the dissolution study of AMO/SP formulations, which was reported for the first time in the open literature. According to the obtained results, the proposed method can be applied in the quality control of pharmaceuticals containing a combination of amoxicillin and sulbactam pivoxil.

PDF

___

[1] WHO, Model List of Essential Medicines, 2019. https://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06. (Accessed on 14 July 2021).
[2] Miller L, Ratnam K, Payne D. β-Lactamase-inhibitor combinations in the 21st century: current agents and new developments. Curr Opin Pharmacol. 2001; 1(5): 451-458. [CrossRef]
[3] Drawz S and Bonomo R. Three decades of β-lactamase inhibitors. Clin Microbiol Rev. 2010; 23(1): 160-201. [CrossRef]
[4] English R, Girard D, Jasys V, Martingano R, Kellogg M. Orally effective acid prodrugs of the β-lactamase inhibitor sulbactam. J Med Chem. 1990; 33(1): 344-347. [CrossRef]
[5] Soutric J, Bantar C, Caruso N, Heguilén R, Casellas J, Casellas J, Farinati A, Jasovich A, Arenoso H, Rodriguez M. Review of pharmacokinetic, pharmacodynamic and clinical studies with a modern combination of amoxicillin/sulbactam. Chemotherapy. 2006; 52(4): 200-204. [CrossRef]
[6] USP, United States of Pharmacopeia in USP30-NF25, The United States Pharmacoepial Convention. 2007.
[7] EP, European Pharmacopoeia 5th Ed., 2005.
[8] FNA, Farmacopea Nacional Argentina F.N.A. 7th Ed., 2003.
[9] Gao Z and Westenberger B. Dissolution testing of acetaminophen suspension using dialysis adapter in flow-through apparatus: a technical note. AAPS Pharm Sci Tech. 2012; 13: 944-948. [CrossRef] [
10] Rivera‑Leyva J, García‑Flores M, Valladares‑Méndez A, Orozco‑Castellanos L, Martínez‑Alfaro M. Comparative studies on the dissolution profiles of oral ibuprofen suspension and commercial tablets using biopharmaceutical classification system criteria. Indian J Pharm Sci. 2012; 74(4): 312-318.
[11] Machado Rubim A, Bandeira Rubenick J, Varini Laporta L, Bueno Rolim C. Development and validation of a dissolution method using HPLC for diclofenac potassium in oral suspension. Braz J Pharm Sci. 2014; 50(2): 423-429. [CrossRef]
[12] Anusha N, Uday Kamath B. Simultaneous estimation of amoxicillin and sulbactam in a parenteral formulation by reverse phase HPLC method. Int J Pharm Pharm. Sci. 2012; 4(4): 330-336.
[13] Chandana P, Srinivas N, Tuljarani G. Development and validation of RP-HPLC method for simultaneous estimation of amoxycillin and sulbactam in binary mixture. Int J Pharma Res Rev. 2015; 5(1): 47-52.
[14] Pei Q, Yang G, Li Z, Peng X, Fan J, Liu Z. Simultaneous analysis of amoxicillin and sulbactam in human plasma by HPLC-DAD for assessment of bioequivalence. Journal of Chromatography B. 2011; 879(21): 2000-2004. [CrossRef]
[15] Wang P, Qi M, Sun Y, Yang J. A liquid chromatographic method for simultaneous determination of amoxicillin sodium and sulbactam sodium in a combination formulation. J Pharm Biomed Anal. 2004; 36(3): 565-569. [CrossRef]
[16] Qi M, Wang P, Sun Y, Wang J. An LC method for simultaneous determination of amoxicillin and sulbactam pivoxil in a combination formulation. J Liq Chrom Relat Tech. 2003; 26(12): 1927-1936. [CrossRef]
[17] Aburjai T, Alzweiri M, Al-Hiari Y. Temperature and pressure behaviours of methanol, acetonitrile/water mixtures on chromatographic systems. Am J Chem. 2011; 2(8): 934-937.
[18] Safaei Z, Bocian S, Buszewski B. Green chromatography-carbon footprint of columns packed with core–shell materials. RSC Advances. 2004; 4(96): 53915-53920. [CrossRef]
[19] ICH, ICH Topic Q2 (R1) Validation of Analytical Procedures: Text and Methodology, International Conference Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use 2005.
[20] Yufera, E, Química orgánica básica y aplicada: de la molécula a la industria, Reverte, Barcelona, Spain 1993. [21] FDA, U.S. Food and Drug Administration. Reviewer guidance, validation of chromatographic methods. 1994. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/reviewer-guidance-validationchromatographic- methods. (Accessed on 14 July 2021).
[22] Aguirre Ortega L. et al. Validación de métodos analíticos. AEFI, Asociación Española de Farmacéuticos de la Industria, Spain, 2001.
[23] Anastas P, Kirchhoff M. Origins, current status, and future challenges of green chemistry. Acc Chem Res. 2002; 35(9): 686-694. [CrossRef]
[24] Fotaki N, Brown W, Kochling J, Chokshi H, Miao H, Tang K, Gray V. Rationale for selection of dissolution media: three case studies. Dissolution Technologies 2013; 20(3): 6-13. [CrossRef]
[25] Niazi S, Handbook of Pharmaceutical Manufacturing Formulations, third ed., CRC Press, Deerfield, Illinois, USA 2000.
[26] Massart DL, Vandeginste BGM, Buydens LMC, De Jong S, Lewi PJ, & Smeyers-Verbeke J, Handbook of Chemometrics and Qualimetrics: Part A: Elservier Science B, Amsterdam, The Netherlands 1997.
[27] ULC 2.0 software, O. Huguet Ibars and R. Boqué Martí, Universitat Rovira i Virgili, Tarragona, Spain 2006.